Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy
This study suggests that an AI-based approach to detect HCC earlier in cirrhotic patients can be cost-effective. By incorporating cost-effective AI-based approaches in clinical practice, patient outcomes and healthcare efficiency are improved.
Authors
- Henry C. Woodruff (ORCID: https://orcid.org/0000-0001-7911-5123)
- Pilar Nicolás Jiménez (ORCID: https://orcid.org/0000-0003-4166-5941)
- Wim Vos (ORCID: https://orcid.org/0000-0003-0827-421X)
- Lieven Annemans (ORCID: https://orcid.org/0000-0001-8305-7210)
- Kaisar Kushibar (ORCID: https://orcid.org/0000-0001-7507-5208)
- Melanie Goisauf (ORCID: https://orcid.org/0000-0002-3909-8071)
- Javier del Riego (ORCID: https://orcid.org/0000-0001-9200-3505)
- Maciej Bobowicz (ORCID: https://orcid.org/0000-0002-3608-1960)
- Samuele Ghezzo (ORCID: https://orcid.org/0000-0002-7765-6759)
- Mickaël Hiligsmann (ORCID: https://orcid.org/0000-0003-4274-9258)
- Jordi Rambla (ORCID: https://orcid.org/0000-0001-9091-257X)
- L.M. Maas (ORCID: https://orcid.org/0000-0002-0032-0712)
- Jordi Rimola (ORCID: https://orcid.org/0000-0002-1814-4198)
- Emanuele Neri (ORCID: https://orcid.org/0000-0001-7950-4559)
- Peter Gordebeke (ORCID: https://orcid.org/0000-0003-1429-7733)
- Fred Prior (ORCID: https://orcid.org/0000-0002-6314-5683)
- Katrine Riklund (ORCID: https://orcid.org/0000-0001-5227-8117)
- Lorenzo Faggioni (ORCID: https://orcid.org/0000-0001-5262-4489)
- Davide Zaccagnini
- Andrea Corsi (ORCID: https://orcid.org/0000-0003-3954-303X)
- Karim Lekadir (ORCID: https://orcid.org/0000-0002-9456-1612)
- Flore Belmans (ORCID: https://orcid.org/0000-0002-8944-6898)
- Martijn P. A. Starmans (ORCID: https://orcid.org/0000-0001-5086-7153)
- Josep Lluís Gelpí (ORCID: https://orcid.org/0000-0002-0566-7723)
- Dariusz Łaski (ORCID: https://orcid.org/0000-0002-1177-4541)
- Marlena Rygusik (ORCID: https://orcid.org/0009-0003-6352-0927)
- Jeroen Cant (ORCID: https://orcid.org/0000-0002-0772-252X)
- Juozas Kupčinskas
- J. Carson Smith
- Tobias Heimann (ORCID: https://orcid.org/0009-0002-8496-5100)
- C. Contreras-Meca
- Xavier Bargalló
- Pär Kragsterman
Institutions
- University of Pisa (IT)
- Lynn University (US)
- University of Liège (BE)
- University of the Basque Country (ES)
- University of Arkansas Medical Center (US)
- Barcelona Supercomputing Center (ES)
- American Association For Cancer Research (US)
- European Society of Radiology (AT)
- Hospital of Lithuanian University of Health Sciences Kaunas Clinics (LT)
- Ghent University (BE)
- Maastricht University (NL)
- Biobanking and Biomolecular Resources Research Infrastructure Consortium (AT)
- Bionomics (Australia) (AU)
- Lynkeus (Italy) (IT)
- European Institute for Biomedical Imaging Research (AT)
- Institute of Research and Innovation Parc Tauli (ES)
- Centre for Genomic Regulation (ES)
- Camber Collective (United States) (US)
- Siemens Healthineers (Germany) (DE)
- Fundació Clínic per a la Recerca Biomèdica (ES)
- Universitat de Barcelona (ES)
- Gdańsk Medical University (PL)
- Umeå University (SE)
- Erasmus University Rotterdam (NL)
- Universitat Politècnica de Catalunya (ES)
- KU Leuven (BE)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1080/13696998.2025.2525006
- Citations
- 4
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Umeå Universitet